Life Sciences Real Estate Transactions Reached US$18b Globally in 2021
What are the Opportunities in Asia Pacific?
Life Sciences real estate transactions reached US$18b globally in 2021, with investment volume increasing in Asia Pacific. This article explores the factors that have helped to fuel demand for life sciences real estate in the region, and how investors can capitalise on significant opportunities in this fast-growing sector.
Greg Hyland
Head of Capital Markets, Asia Pacific, CBRE
Greg Hyland is the Head of Capital Markets, Asia Pacific for CBRE. Based in Singapore, he is responsible for all of CBRE’s Capital Markets teams across the region. With over 20 years of experience, Greg has positioned himself as one Asia Pacific’s leading Capital Markets professionals and established deep relationships with some of the world’s leading real estate investors.
Dr. Henry Chin
Global Head of Investor Thought Leadership and Head of Research, Asia Pacific, CBRE
Dr Henry Chin is the Global Head of Investor Thought Leadership and Asia Pacific Head of Research at CBRE. Henry leads a global research team to identify the key forces influencing commercial real estate investors across all sectors and collaborates closely with CBRE clients to help them understand the intricacies of property markets and make strategic investment decisions.
Other Articles
Introduction - Technology: From Disruption to Innovation
Sigrid Zialcita
CEO
Asia Pacific Real Assets Association
The Impact of Inflation and Rising Interest Rates on Infrastructure Investing
David Walsh
Managing Director
Goldman Sachs